Navigation Links
Experimental Drug Helps Fight Aggressive Breast Cancer: Report
Date:1/6/2011

By Amanda Gardner
HealthDay Reporter

WEDNESDAY, Jan. 5 (HealthDay News) -- Researchers have taken another step in the hunt to find a treatment for an aggressive, likely-to-recur form of breast cancer.

In a study published in the Jan. 5 online edition of the New England Journal of Medicine, the experimental drug iniparib not only shrank tumors and increased the time they took to progress, but also surprised researchers by prolonging survival in women with what's known as triple-negative breast cancer.

This type of breast cancer lacks receptors for estrogen and progesterone and doesn't have large quantities of HER-2/neu protein, which the most successful cancer therapies target. This means that many currently available drugs simply won't affect it.

"We were surprised [at the results] because triple-negative breast cancer is very difficult to treat," said study lead author Dr. Joyce O'Shaughnessy.

"The big, big surprise was survival," added O'Shaughnessy, who nevertheless stressed that the trial was small and preliminary.

The findings were enough to generate the interest of Dr. Lisa A. Carey, the co-author of an accompanying editorial.

"It is early, but it's really exciting because it's a new class of drugs. It isn't that often that we have a completely new approach to treating cancer," said Carey, medical director of the University of North Carolina Breast Center in Chapel Hill. "This is a new book. We've just opened it up."

Iniparib inhibits a pathway that helps repair DNA; researchers call it the poly(ADP-ribose) polymerase (PARP) pathway. If this chain is interrupted, cancer cells don't have the necessary tools to repair themselves.

"[PARP inhibitors] work by preventing the cells from repairing damage to their DNA," Carey explained.

A similar drug, in fact, has shown benefit in patients with BRCA 1 or BRCA 2 mutations predisposing them to breast and ovari
'/>"/>

Copyright©2010 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Experimental Drug Offers Hope for Cystic Fibrosis Patients
2. Experimental Vaccine Shields Monkeys Against Ebola
3. Experimental targeted therapy shows early promise against medulloblastomas
4. Experimental nonsteroidal treatment of asthma shows promise
5. Experimental obesity drug avoids brain effects that troubled predecessors
6. Experimental treatments for cocaine addiction may prevent relapse
7. Experimental TB Test Called Fast and Accurate
8. Experimental Drug Shows Promise for Bone Marrow Disorder
9. Experimental Leukemia Drug Proves a Slam Dunk
10. Experimental Test May Spot Prostate Cancer Earlier, More Accurately
11. Experimental Drug Aids Kids With Nervous System Tumor
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Experimental Drug Helps Fight Aggressive Breast Cancer: Report
(Date:2/28/2015)... Mew and Company, a Vancouver corporate tax ... business consulting services in addition to a variety of ... succession planning. Company finances are a complicated matter that ... of this, complex Canadian tax laws can make it ... result, Mew and Company works to advise their clients ...
(Date:2/28/2015)... A study out of the University of Oxford ... the treatment of a hereditary ocular condition that leads ... Dr. Robert MacLaren, professor of ophthalmology at the University ... on January 16, 2014 , the study treated six ... mostly affects men and leads to the degeneration of ...
(Date:2/28/2015)... (PRWEB) February 28, 2015 Pioneer Millworks ... 2015 Japan Architecture & Construction Materials Show, an annual, ... more than 1,000 suppliers and top manufacturers of the ... Reclaimed wood products sourced and manufactured by Pioneer ... found popularity in Japan at restaurants, hotels, retailers, and ...
(Date:2/28/2015)... 28, 2015 India Network Foundation, ... visitor health insurance programs for visitors coming to the ... elderly parents traveling to the United States are suffering ... and blood pressure. These diseases are so common among ... them as medical conditions. There were 66.8 million cases ...
(Date:2/28/2015)... How would you describe your ... are all kinds of different leaders, each with ... the advantages and applications of different leadership styles, ... new product this spring called The Leadership Report ... between personality type, leadership, and success. The Leadership ...
Breaking Medicine News(10 mins):Health News:Vancouver Corporate Tax Accountants Now Provide Business Consulting Services 2Health News:New Gene Therapy Procedure Could Hold Key to Preventing Blindness for Certain Patients 2Health News:US Reclaimed Wood from Pioneer Millworks to be Featured at Architecture & Construction Materials Show in Tokyo. 2Health News:India Network Announces Pre-existing Condition Health Insurance Coverage for Diabetic Visitors of All Ages Traveling to the United States 2Health News:India Network Announces Pre-existing Condition Health Insurance Coverage for Diabetic Visitors of All Ages Traveling to the United States 3Health News:PeopleKeys Launches The Leadership Report 2Health News:PeopleKeys Launches The Leadership Report 3
... (WHI) confirm that combination hormone therapy increases the risk of ... trend toward an increased risk of heart disease during the ... therapy within 10 years of menopause, and a more marked ... than 10 years after menopause. Analyses indicate that overall ...
... Feb. 15, 2010 Simple urine tests for four ... people with lupus, researchers at UT Southwestern Medical Center have ... years before such tests could be used clinically, the findings ... in use, the researchers said. "Our goal was to ...
... thought they were fine, while their docs disagreed , TUESDAY, ... and diabetes, a new survey has found that a majority ... everyone else who has the problem. , More than 50 ... in the wrong direction." In contrast, only 17 percent said ...
... Telecom ... ... Group, a Harte-Hanks Company has released a new benchmark report entitled Recovering with Telecom ... solutions as a strategic foundation and precursor for other communications and network investments in ...
... ... professionals and scientists doing the critical work of IP research are seeking the best ... includes lunch and roundtable discussion., , ... (Vocus) February 16, 2010 -- GenomeQuest will hosts a seminar focused ...
... YORK , Feb. 16 Paco Sosa , ... had cheated death several times in recent years, passed away on ... , According to his companion, filmmaker Bernadine Santistavan, Paco acknowledged his ... him go. , For Dr. Thalia Goldberg at Park ...
Cached Medicine News:Health News:WHI data confirm short-term heart disease risks of combination menopausal hormone therapy 2Health News:WHI data confirm short-term heart disease risks of combination menopausal hormone therapy 3Health News:WHI data confirm short-term heart disease risks of combination menopausal hormone therapy 4Health News:Urine protein test might help diagnose kidney damage from lupus, UT Southwestern researchers find 2Health News:Most Americans Think It's Others Who Are Unhealthy 2Health News:Most Americans Think It's Others Who Are Unhealthy 3Health News:AnchorPoint Sponsored Aberdeen Group Report Addresses Telecom Lifecycle Management 2Health News:AnchorPoint Sponsored Aberdeen Group Report Addresses Telecom Lifecycle Management 3Health News:AnchorPoint Sponsored Aberdeen Group Report Addresses Telecom Lifecycle Management 4Health News:AnchorPoint Sponsored Aberdeen Group Report Addresses Telecom Lifecycle Management 5Health News:GenomeQuest Hosts Seminar Focused On Web-based Searching for Patent Information Across Global Sequence Databases 2Health News:Manhattan's Oldest Dog Dies, Leaves Behind a Legacy of Teaching 2
(Date:2/27/2015)... , Feb. 27, 2015  Boston Scientific Corporation ... in the Barclays 2015 Annual Healthcare Conference on March ... Dan Brennan , executive vice president and ... president, Investor Relations, will participate in a 25-minute question ... analyst at approximately 1:05 p.m. ET. Following a 5-minute ...
(Date:2/27/2015)... 2015 /CNW/ - Covalon Technologies Ltd. (the "Company" or "Covalon") ... financial results for its first quarter ended December 31, ... December 31, 2014, revenue was $1,336,685. Operating expenses were ... $0.02 per share.  Covalon,s President and ... pleased with the significant progress we have made over ...
(Date:2/27/2015)... , Feb. 27, 2015  Uroplasty, Inc. (NASDAQ: ... and markets innovative proprietary products to treat voiding dysfunctions, ... Annual ROTH Conference on Tuesday, March 10, 2015. ... Reynolds , Chief Financial Officer, will present at 4:00 ... one at the conference at the Ritz Carlton in ...
Breaking Medicine Technology:Boston Scientific to Participate in the Barclays 2015 Annual Healthcare Conference 2Covalon Announces First Quarter Financial Results 2Covalon Announces First Quarter Financial Results 3Uroplasty to Participate in the 27th Annual ROTH Conference 2
... of Ang II is a ... pharmacological effect and efficiency of ... converting enzyme inhibitors (ACE Inhibitors) ... as well as for the ...
Anti-RSV IgM Assay (ELISA)....
One step Immunochromatographic Assay for the detection of Respiratory Syncytial Virus...
Immunofluorescence test for detecting RSV in direct specimens and cultures....
Medicine Products: